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Dear Editors,
Prenatal exposure to maternal smoking (PEMS) has been linked to diverse negative perinatal 
outcomes (Cnattingius, 2004) and far-reaching neurobehavioral consequences, including 
impaired cognition, attention-deficit/hyperactivity disorder, and conduct disorder (Cornelius 
and Day, 2009; Gaysina et al., 2013). Although one study did not demonstrate a link 
between PEMS and risk for schizophrenia (Baguelin-Pinaud et al., 2010), Stathopoulou et 
al. (2013) found that prenatal tobacco exposure was independently associated with a later 
schizophrenia diagnosis. Ekblad et al. (2010) reported that the exposure is associated with 
increased risk of psychiatric morbidity including broadly defined psychosis. Other studies 
suggested that PEMS might increase risk for psychotic symptoms in offspring (Spauwen et 
al., 2004; Zammit et al., 2009). PEMS could conceivably impact illness manifestation 
among individuals with psychotic disorders. Smith et al. (2010) showed no association with 
symptom type or severity, or with symptom change across one year, among first-episode 
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psychosis (FEP) patients, but Stathopoulou et al. (2013) found that PEMS was related to 
greater severity of negative symptoms.
Given limited/inconsistent findings to date, we examined associations between PEMS and 
symptom severity among FEP patients, while controlling for effects of gender and the 
patient’s own smoking status. Participants (N = 93; age = 22.7 ± 3.7 years; 75.3% male; 
91.4% African American) were recruited during an initial hospitalization as part of a larger 
study. Their biological mothers completed a questionnaire including items on smoking 
during the pregnancy. Data on current/past-month symptom severity were collected with the 
Positive and Negative Syndrome Scale (Kay et al., 1987). Comparisons between those with 
and without PEMS were made using Student’s t-tests, and factorial analyses of variance 
(ANOVAs) to examine effects of gender and current smoking status.
Among the 93 mothers, 19 (20.4%) had smoked during pregnancy. The average number of 
cigarettes smoked per month during pregnancy was 113.7. As shown in Table 1, the two 
groups of FEP patients did not significantly differ on mean PANSS positive symptom 
severity. However, those with PEMS had greater severity of reality distortion: 13.6 ± 2.8 vs. 
11.6 ± 3.0; t = 2.64, df = 91, p = .01; the difference being driven by greater hallucination 
severity (5.2 ± 1.3 vs. 4.0 ± 1.6; t = 3.06, df = 91, p = .003). Controlling for potential effects 
of gender and smoking status did not eliminate the effect of PEMS on reality distortion. 
Gender and smoking status were not significant predictors, but there was a main effect of 
PEMS (F(1, 79) = 4.94, p = .029). No interactions were observed.
The two groups did not differ significantly on mean PANSS negative symptom severity 
(Table 1). However, those with PEMS had lower severity of deficit symptoms (PANSS proxy 
for the deficit syndrome score): −7.1 ± 3.1 vs. −4.0 ± 3.3; t = 3.69, df = 91, p < .001. 
Controlling for potential effects of gender and smoking status did not eliminate the effect of 
PEMS on deficit symptom severity. Gender was not a significant predictor, but there were 
independent main effects of PEMS (F(1, 79) = 4.66, p = .034), and current smoking status 
(F(1, 79) = 4.57, p = .036). There were no interactions.
Although these initial results require replication, there appears to be an association between 
PEMS and greater hallucination severity at initial hospitalization for FEP. This is consistent 
with limited prior studies indicating that PEMS may elevate risk for psychotic symptoms/
disorders (Spauwen et al., 2004; Zammit et al., 2009; Ekblad et al., 2010). We found a lower 
severity of deficit symptoms, which is inconsistent with the prior report indicating that 
PEMS was associated with greater negative symptom severity (Stathopoulou et al., 2013).
Several methodological limitations must be acknowledged: the cross-sectional/retrospective 
nature of the study, potential for social desirability bias among the mothers, and limited 
sample size. Nonetheless, our findings suggest that—in addition to potentially increasing 
risk for psychotic symptoms/disorders—this fetal environmental exposure might worsen 
severity of hallucinations among those with early-course psychosis.
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